Emerging evidence strongly suggests that dysregulation within the PAS, specifically involving imbalances in uPA and tPA activity and PAI-1 levels, contributes significantly to the development, progression, and treatment response in depressive disorders. This evidence concerns the gene SERPINE1 and depressive disorder.